Stephen Charles Emery

Person

Macclesfield, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies directed to angiopoietin-2 and uses thereof
- Patent number 10,066,011
- Issue date Sep 4, 2018
- MedImmune Limited
- Larry L. Green
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed to angiopoietin-2 and uses thereof
- Patent number 8,834,880
- Issue date Sep 16, 2014
- MedImmune Limited
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted binding agents directed to uPAR and uses thereof
- Patent number 8,026,344
- Issue date Sep 27, 2011
- MedImmune Limited
- Qing Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to angiopoietin-2 and uses thereof
- Patent number 7,973,140
- Issue date Jul 5, 2011
- MedImmune Limited
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibody to CEA, conjugates comprising said antibody and...
- Patent number 6,903,203
- Issue date Jun 7, 2005
- Astrazeneca UK Ltd.
- Clive Graham Copley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vector for expression of GPI-enzyme hybrid
- Patent number 6,838,446
- Issue date Jan 4, 2005
- Astrazeneca AB
- Stephen C. Emery
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene construct encoding a heterologous prodrug-activating enzyme an...
- Patent number 6,339,070
- Issue date Jan 15, 2002
- Zeneca Limited
- Stephen Charles Emery
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CEA antibody designated 806.077, hybridoma and method of manuf...
- Patent number 6,277,599
- Issue date Aug 21, 2001
- Zeneca Limited
- Clive Graham Copley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20160251421
- Publication date Sep 1, 2016
- MEDIMMUNE LIMITED
- Jeffrey Lester BROWN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF
- Publication number 20150125455
- Publication date May 7, 2015
- MEDIMMUNE LIMITED
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20140023654
- Publication date Jan 23, 2014
- MEDIMMUNE LIMITED
- Jeffrey Lester BROWN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF
- Publication number 20130171160
- Publication date Jul 4, 2013
- MEDIMMUNE LIMITED
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20120288497
- Publication date Nov 15, 2012
- MEDIMMUNE LIMITED
- DAVID CHARLES BLAKEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF
- Publication number 20120108797
- Publication date May 3, 2012
- MEDIMMUNE LIMITED
- Paul Elvin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed to Angiopoietin-2 And Uses Thereof
- Publication number 20120052073
- Publication date Mar 1, 2012
- Medlmmune Limited
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20110097321
- Publication date Apr 28, 2011
- AstraZeneca AB
- David Charles Blakey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF
- Publication number 20090123476
- Publication date May 14, 2009
- AstraZeneca AB
- Paul Elvin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20090123474
- Publication date May 14, 2009
- AstraZeneca AB
- David Charles Blakey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed to Angiopoietin-2 and Uses Thereof
- Publication number 20080267971
- Publication date Oct 30, 2008
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS DIRECTED TO uPAR AND USES THEREOF
- Publication number 20080152587
- Publication date Jun 26, 2008
- Amgen Fremont Inc.
- Qing Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to angiopoietin-2 and uses thereof
- Publication number 20060246071
- Publication date Nov 2, 2006
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoclonal antibody to CEA, conjugates comprising said antibody, an...
- Publication number 20020142359
- Publication date Oct 3, 2002
- Clive Graham Copley
- B82 - NANO-TECHNOLOGY

Stephen Charles Emery

Person

Patents Grantslast 30 patents

Antibodies directed to angiopoietin-2 and uses thereof

Antibodies directed to angiopoietin-2 and uses thereof

Targeted binding agents directed to uPAR and uses thereof

Antibodies directed to angiopoietin-2 and uses thereof

Monoclonal antibody to CEA, conjugates comprising said antibody and...

Vector for expression of GPI-enzyme hybrid

Gene construct encoding a heterologous prodrug-activating enzyme an...

Anti-CEA antibody designated 806.077, hybridoma and method of manuf...

Patents Applicationslast 30 patents

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF

Antibodies Directed to Angiopoietin-2 And Uses Thereof

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

Antibodies Directed to Angiopoietin-2 and Uses Thereof

TARGETED BINDING AGENTS DIRECTED TO uPAR AND USES THEREOF

Antibodies directed to angiopoietin-2 and uses thereof

Monoclonal antibody to CEA, conjugates comprising said antibody, an...